Enfermedad del legionario en Argentina: evolución de la estrategia diagnóstica en el laboratorio
Revista Argentina de Microbiología · 2023
DOI: 10.1016/j.ram.2022.10.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista Argentina de Microbiología, 2023. Verfasst von Lucía Cipolla und 4 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Nacional de Enfermedades Infecciosas, ANLIS Dr. Carlos Malbrán, Ciudad Autónoma de Buenos Aires, Argentina. Hauptthemen laut MEDLINE: Legionnaires' Disease, Legionella pneumophila. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Legionnaires' disease (LD) is severe acute pneumonia that occurs in sporadic or epidemic form, and generally requires hospitalization. The objective of this work was to describe the experience in the LD laboratory diagnostic approach in Argentina during the period 2016-2021. The laboratory analyzed 168 clinical specimens from 93 cases of suspected LD pneumonia. Laboratory tests included the detection of the soluble antigen of Legionella pneumophila serogroup 1 in urine sample, detection of DNA of Legionella spp. in lower respiratory secretions by conventional and commercial molecular methods and isolation in selective medium. LD was confirmed in 12 patients. The urinary antigen allowed the diagnosis for 8 patients. L. pneumophila was isolated from the respiratory material of 6 patients suffering from health care-associated pneumonia, who had been previously diagnosed using the commercial molecular method. Fifty percent of these cases did not show detectable urinary antigen. A single patient did not shows neither detectable antigenuria nor isolation of Legionella from the respiratory sample and was diagnosed as a confirmed case of LD by the detection of DNA of Legionella spp. by PCR directly from the respiratory secretion and the epidemiological link with another case of confirmed LD by culture. Urinary antigen detection is the first-line diagnostic test. However, the incorporation of complementary molecular methods has proved to avoid false negatives and contributed to a better understanding of the true incidence of the disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto Nacional de Enfermedades Infecciosas, ANLIS Dr. Carlos Malbrán, Ciudad Autónoma de Buenos Aires, Argentina.
- Instituto Nacional de Enfermedades Infecciosas, ANLIS Dr. Carlos Malbrán, Ciudad Autónoma de Buenos Aires, Argentina. Electronic address: pmaprieto@gmail.com.
Zitieren
APA
Cipolla, L., Rocca, F., Armitano, R., López, B., & Prieto, M. (2023). Enfermedad del legionario en Argentina: evolución de la estrategia diagnóstica en el laboratorio. Revista Argentina de Microbiología. https://doi.org/10.1016/j.ram.2022.10.001
Vancouver
Cipolla L, Rocca F, Armitano R, López B, Prieto M. Enfermedad del legionario en Argentina: evolución de la estrategia diagnóstica en el laboratorio. Revista Argentina de Microbiología. 2023. doi:10.1016/j.ram.2022.10.001
BibTeX
@article{Cipolla2023,
author = {Cipolla, Lucía and Rocca, Florencia and Armitano, Rita and López, Beatriz and Prieto, Mónica},
title = {Enfermedad del legionario en Argentina: evolución de la estrategia diagnóstica en el laboratorio},
journal = {Revista Argentina de Microbiología},
year = {2023},
doi = {10.1016/j.ram.2022.10.001}
}
EUVIMED